Expand search form

A Voice for Private Physicians Since 1943

COVID-19: Got the Shot—What Next?

Are you one of the “hesitant” Americans facing the “jab or no job” deadline? Or contemplating a booster for yourself or a jab for your child?

You could believe Dr. Fauci, the AMA, Pfizer, Joe Biden, CNN, and the countless others who say the vaccine is “safe and effective,” so just do it. Or you could wonder whether one of those “extremely rare” side effects could happen to you.

Adverse reactions involve blood clots and inflammation. Early identification and treatment could be life-saving. You might want to get some tests—just in case. If there’s a sign of a problem, you might get treatment—or a medical exemption from additional shots, noting that reactions to the second dose may be much more severe.

D-dimers in the blood signify a blood-clotting problem. A former emergency-room physician said she was seeing extremely high levels in vaccinated patients, even higher than 5,000 ng/mL (normal is less than 500). Since most did not have signs of a pulmonary embolus or deep vein thrombosis, she suggested that there might be microscopic clots in tiny vessels, which might lead to organ damage. Dr. Charles Hoffe of Canada estimates that about 60% of patients have an elevated level four to seven days after the shot. This measure was not included in the official vaccine trials. . Doctors  for Covid Ethics is conducting a study.

Clotting is also a feature of COVID-19 disease, leading some physicians to recommend aspirin or stronger “blood thinners” in their treatment protocols.

Myocarditis or pericarditis has been in the news, as more than 20 world-class athletes have collapsed on playing fields, an event previously witnessed only about once a year. If diagnosed, it is treatable, with anti-inflammatory drugs and exercise restriction. Tests include C-reactive protein (CRP), a nonspecific inflammatory marker, and level of troponin, which is released from damaged heart cells. Cardiologist Peter McCullough, M.D., reports seeing levels higher than from a heart attack in post-vaccination myocarditis.

Vaccine manufacturers did not look for this in pre-authorization trials, and FDA is requiring studies with a 5-year follow up as a condition of licensing Comirnaty, which is very similar to the Pfizer product that is available in the U.S. under an Emergency Use Authorization. The FDA letter stated that the spontaneous reporting of adverse events “will not be sufficient to assess known serious risks of myocarditis and pericarditis and identify an unexpected serious risk of subclinical myocarditis.”

It is possible that “subclinical” inflammation that has no symptoms or perhaps just mild fatigue could cause permanent damage.

Patients might also want to know their CD4 and CD8 lymphocyte counts as measures of the strength of their immune system, which protects them against infection and cancer.

While employers claim to grant medical exemptions, many if not most are declined. The existence of a qualifying pre-existing condition does not identify all persons at risk for vaccine adverse reactions. These post-vaccine tests may serve of a warning of adverse reactions to subsequent doses.

Additional information:

Previous Article

Sometimes It Takes a Puppy

Next Article

Biden’s Bounty on Your Life: Hospitals’ Incentive Payments for COVID-19